The #ACCVFEDS just wrapped an epic webinar on #NuclearImaging 🔬✨ From #SPECT ➡️ #PET ❤️‍🔥 Catch the recording 🎥👉 https://t.co/7S78L7Dxpm Dive into PET basics, clinical wins, vet-focused care 🇺🇸 & the new tracer Flurpiridaz! 🔥

#TCT2025 STORM-PE trial. Penumbra Thrombectomy vs AC alone for intermediate risk PE. Superior improvement in RV/LV ratio with Thrombectomy vs AC alone. #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @MartyBLeon

💥 The #VICTORY Trial presented at #TCT2025: In OCT-guided PCI for severely calcified coronary lesions, OPN non-compliant balloon was non-inferior to intravascular lithotripsy (IVL) for stent expansion — with fewer devices, shorter procedures, and lower cost. #TCT2025

🔍 Large-bore vascular closure: ProGlide or MANTA? A new patient-level meta-analysis of randomized trials by Oliver Dumpies et al. compares outcomes between these two commonly used devices. ➡️ Result: ProGlide was associated with fewer vascular and bleeding complications than the

#TCT2025 DEB vs DES in de novo lesion! SELUTION trial. Deb is Non inferior to DES. This is going to be future. Stents are great but no metal left behind in 2-5 mm vessels is the way to go. #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos

SELUTION DeNovo 🇪🇺 | #TCT2025 Large, pragmatic strategy trial: sirolimus DCB-first vs contemporary DES for de novo lesions. Unique strategy: patients randomized before lesion preparation — unlike prior DCB studies. ✅ Non-inferior for 1-year TVF (5.3% vs 4.4%) 💀 Death, MI,

💥 The #ShortCUT Trial at #TCT2025: In imaging-guided PCI of calcified lesions, cutting balloon angioplasty was non-inferior to intravascular lithotripsy (IVL) for stent expansion and MSA with significantly lower procedural cost. A pragmatic study with important

@WKayaniMD @BaylorCardio @MusaSharkawiMD @ShariqShamimMD @jedicath @mmamas1973 @SCAI @SanChris999 @Obisht @DrIHHashmi1 @HadyLichaaMD @ashaukat09 @TWilsonMD @jl35wilsonMD @DrBIqbal @Almanfi_Cardio @DrJayMohan @AntoniousAttall @PCRonline @EuroInterventio @nyalborgesmd @crfheart

Unusual case: Pt with CABG (2017) now with unstable angina. Cath revealed severe ostial LIMA stenosis & severe LAD disease. Isn’t LIMA protected from atherosclerosis? 🤔 No prior caths since CABG; LIMA never selectively engaged here👇 #CardioTwitter #ACCFIT #Cardiology

Thank you #CardioTwitter for your input. Ended up doing the case percutaneously. The large 48 mm Gore device sealed the ASD well 👇

And the winner and 3-time champion of @txchapteracc #accfitjeopardy is…. @UTSWCardfellow UT Southwestern!!! A thrilling final for the ages worthy of a national @ACCinTouch finals performance! @BCMHeart , @utmbcardiology , @BSWTemple_CVdoc all with impressive performances!

It takes a village to run #tcacc25 @txchapteracc @ACCinTouch #accfitjeopardy - couldn’t happen w/o power team: @DrDeepa1020 @dr_chebrolu @Umair2017 Pooja Sethi @DocBrownAB Dan Cheeran from @UTHealthHouston @HMHCardioFellow @BCMHeart @TTUHSC @UTSWCardfellow THX 4 all y’all do!

🔥 Round 1 of #ACCFitJeopardy is in the books! 🔥 An epic showdown between @BCMHeart @utmbcardiology @HMHCardioFellow @HCAHoustonCVD 🩺 #TCACC2025 #ACCFIT #CardioTwitter

Coronary injury pattern across #calcium modifications strategies .. #lithotripsy vs #cutting_balloons vs #Ultra_high_pressure balloon Check out this interview with @AlokeFinn @CVPath_Md discussing their #cadaveric study👇🏽 https://t.co/P1PUGuU64Q @JACCJournals #CardioX

A 70-year-old man with inferior STEMI. What's your take on the likely culprit vessel, and how would you manage this case?

It was great chatting with the Chair of ACC Board of Governors @drdavemd about acing the transition from FIT to faculty & setting yourself up for success! @ACCinTouch @nbwiggins @noshreza @SanChris999 @Pooh_Velagapudi @Babar_Basir @ZainAsadCardOnc @Umair2017 @aayshacader

There you go! #PSAthrombinInjection https://t.co/eIGa7YJZoY @MichaelMegalyMD @sanjum @DrJayMohan @sahilparikhmd @SripalBangalore @SDhandMD @AaronFrittsMD @_backtable @SCAI @anishthomasmd @JayMathewsMD @Umair2017 @mirvatalasnag @Babar_Basir @agtruesdell @Murmur_MDApp

Check out my interview with @G_Tarantini01 on his recent @JACCJournals publication discussing coronary access after #TAVR (#CavEAT study). #Cardiotwitter #ACCFIT #Cardiology #MedTwitter #JACCINT 👉 https://t.co/jP2yY231gg

@aayshacader @AbdullahAlabcha @netta_doc @ChrisCheungMD @docbhardwaj @EiranGorodeski @drmeghaprasad @AbdullahAlabcha @AChoiHeart @jeffreygeske @JeffHsuMD @VascRes @GiselleSA_MDPhD @Dr_Mike_Fradley @DrRaulCordoba @BakhshiHooman @IndahSP_MD @MrinShettyMD @ABeneduceMD

As the #JACCINT SoMe Editor, had the opportunity to interview 1st Author, Dr. Ciardetti, for his publication on DCB use for CTO-PCI last week 👇 #CardioTwitter #ACCFIT @JACCJournals #Cardiology